JP2007533600A5 - - Google Patents

Download PDF

Info

Publication number
JP2007533600A5
JP2007533600A5 JP2006521597A JP2006521597A JP2007533600A5 JP 2007533600 A5 JP2007533600 A5 JP 2007533600A5 JP 2006521597 A JP2006521597 A JP 2006521597A JP 2006521597 A JP2006521597 A JP 2006521597A JP 2007533600 A5 JP2007533600 A5 JP 2007533600A5
Authority
JP
Japan
Prior art keywords
mmol
reaction
stir
hours
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006521597A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007533600A (ja
JP4343227B2 (ja
Filing date
Publication date
Priority claimed from ES200301781A external-priority patent/ES2222822B1/es
Application filed filed Critical
Publication of JP2007533600A publication Critical patent/JP2007533600A/ja
Publication of JP2007533600A5 publication Critical patent/JP2007533600A5/ja
Application granted granted Critical
Publication of JP4343227B2 publication Critical patent/JP4343227B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006521597A 2003-07-28 2004-07-23 生物活性剤の投与のためのアジュバントとして有効である非α位のアミノ酸ジアミド Expired - Fee Related JP4343227B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200301781A ES2222822B1 (es) 2003-07-28 2003-07-28 Diamidas de aminoacidos en posicion no alfa utiles como adyuvantes para la administracion de agentes biologicos activos.
PCT/ES2004/000346 WO2005012230A1 (es) 2003-07-28 2004-07-23 DIAMIDAS DE AMINOACIDOS EN POSICION NO α UTILES COMO ADYUVANTES PARA LA ADMINISTRACION DE AGENTES BIOLOGICOS ACTIVOS

Publications (3)

Publication Number Publication Date
JP2007533600A JP2007533600A (ja) 2007-11-22
JP2007533600A5 true JP2007533600A5 (enExample) 2009-07-09
JP4343227B2 JP4343227B2 (ja) 2009-10-14

Family

ID=34112519

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006521597A Expired - Fee Related JP4343227B2 (ja) 2003-07-28 2004-07-23 生物活性剤の投与のためのアジュバントとして有効である非α位のアミノ酸ジアミド

Country Status (17)

Country Link
US (1) US7462735B2 (enExample)
EP (1) EP1652836B1 (enExample)
JP (1) JP4343227B2 (enExample)
KR (1) KR100970216B1 (enExample)
CN (1) CN100475776C (enExample)
AT (1) ATE367373T1 (enExample)
AU (1) AU2004261417C1 (enExample)
BR (1) BRPI0413032A (enExample)
CA (1) CA2533639A1 (enExample)
DE (1) DE602004007665T2 (enExample)
DK (1) DK1652836T3 (enExample)
ES (2) ES2222822B1 (enExample)
PL (1) PL1652836T3 (enExample)
PT (1) PT1652836E (enExample)
RU (1) RU2368599C2 (enExample)
WO (1) WO2005012230A1 (enExample)
ZA (1) ZA200600165B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2060253A1 (en) 2007-11-14 2009-05-20 Laboratorios Farmaceuticos Rovi, S.A. Pharmaceutical forms for the release of active compounds
ES2296529B1 (es) * 2006-08-07 2009-04-01 Laboratorios Farmaceuticos Rovi, S.A. Composicion farmaceutica con promotores de absorcion.
US8802156B2 (en) 2007-11-14 2014-08-12 Laboratorios Farmacéuticos Rovi, S.A. Pharmaceutical forms for the release of active compounds
EP2213282A1 (en) 2009-01-30 2010-08-04 Laboratorios Farmaceuticos Rovi, S.A. Pharmaceutical forms for the release of active compounds
CN104230745B (zh) * 2014-07-10 2016-06-22 南京医科大学 一类n-苄基取代的氨基水杨酸与4-氨基丁酸的酰胺衍生物及其药物用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001347A (en) 1995-03-31 1999-12-14 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5965121A (en) * 1995-03-31 1999-10-12 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5650386A (en) * 1995-03-31 1997-07-22 Emisphere Technologies, Inc. Compositions for oral delivery of active agents
US6358504B1 (en) * 1997-02-07 2002-03-19 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
WO2000007979A2 (en) * 1998-08-07 2000-02-17 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
WO2000031536A2 (en) * 1998-11-23 2000-06-02 President And Fellows Of Harvard College Detecting structural or synthetic information about chemical compounds
SE0102764D0 (sv) * 2001-08-17 2001-08-17 Astrazeneca Ab Compounds

Similar Documents

Publication Publication Date Title
JP6181168B2 (ja) ある種の2−(ピリジン−3−イル)チアゾール類の製造方法
JP2017509707A5 (enExample)
RU2593752C1 (ru) Соединения, пригодные для синтеза бензамидных соединений
CA2419722A1 (en) Benzoic acid derivatives and drugs containing the same as the active ingredient
KR101058284B1 (ko) 2-(2-n-부틸-4-히드록시-6-메틸-피리미딘-5-일)-N,N-디메틸아세트아미드의 신규한 제조방법
JP2007533600A5 (enExample)
CN104003853A (zh) 一种查尔酮衍生物及其应用
CN103922999B (zh) 一种达比加群酯中间体的制备方法及中间体化合物
CN108358865B (zh) 一种多取代噻唑类化合物的制备方法
CN105189467A (zh) 制备哒嗪酮化合物的方法
CN101585819A (zh) 1,2,3-噻二唑巯乙酰胺类衍生物的制备方法
JP2003534243A5 (enExample)
JP4607917B2 (ja) 8−アミノ−4−オキソ−2−(テトラゾール−5−イル)−4h−1−ベンゾピランまたはその塩の製造方法、及びその製造用中間体
RU2698202C2 (ru) СПОСОБ ПОЛУЧЕНИЯ ПРЯМОГО ИНГИБИТОРА ФАКТОРА Ха
EP3165521B1 (en) Method of preparing dabigatran etexilate intermediate and intermediate compound
CN111072586A (zh) 一种n-羟基-3-取代-5-甲酰胺化合物及其制备方法和用途
CN104030977B (zh) 一种达比加群酯中间体的制备方法
CN103724221B (zh) 一种酰胺类化合物、其中间体的制备方法及其中间体
JP2013221025A (ja) ビフェニルアセトアミド誘導体の製造方法及びその中間体
CN111253369A (zh) 一种苯磺酸盐、其制备方法及其在制备达比加群酯中的应用
CN106608874A (zh) 2-[5-(氮唑-1-基)噻唑-2-亚氨基]噻唑啉酮及其制备方法与应用
KR101345471B1 (ko) 3,4-디히드로퀴나졸린 유도체의 제조방법 및 이를 위한 중간체
JP2009504721A (ja) 化学工程
KR20250053629A (ko) Atx 저해용 화합물, 이의 제조방법 및 이를 유효성분으로 포함하는 atx 활성 관련 질환의 예방 또는 치료용 약학적 조성물
CN104788398A (zh) 苯并恶唑类化合物及其制备方法和用途